Allianz Life Insurance Malaysia Calls for Strategic Public-Private Healthcare Partnerships to Mitigate Medical Claim Inflation

Kuala Lumpur, 26 August 2026 – Allianz Life Insurance Malaysia Berhad Chief Executive Officer has issued an urgent appeal to healthcare policymakers, private hospital operators, and medical regulatory bodies to establish a formalized, institutionalized public-private healthcare collaboration framework to manage escalating medical claim inflation and protect the long-term financial accessibility of private health insurance for Malaysian households.

Speaking during an executive healthcare leadership symposium in Kuala Lumpur, the life insurance chief highlighted that medical claim inflation in Malaysia has surged into double digits, averaging between 12.5% and 14.8% annually over the past three years. This rapid cost escalation, driven by advancing medical diagnostic technologies, rising pharmaceutical import costs, increasing lifestyle-related chronic disease burdens, and non-standardized private hospital itemized billing, imposes unsustainable cost pressures on life insurers and policyholders alike, necessitating periodic premium repricing that risks pricing lower- and middle-income families out of private healthcare coverage.